Skip to content

Effect of Shishukalyanaka Ghrita in CP Children

Assessment of Shishukalyanaka Ghrita on Decelerated Milestone in Cerebral Palsy Children

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016092
Enrollment
30
Registered
2018-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cerebral Palsy

Interventions

Intervention1: Shishukalyanaka Ghrita, Yogendra Rasa, Muktashukti Bhasma, Khanjankari Bhasma, Bahya Snehana,Bala-Jivanti seerpaka, Vachamoola & almond, Shiropichu, Panchakarma: Shishukalyanaka Ghrita

Sponsors

Dept of Kaumarbhritya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cerebral palsy children suffering from any types of CP due to different etiology especially due to perinatal asphyxia. 2. Patients who have underwent cerebral imaging and EEG. 3.Patient has received therapy at least from one pediatrician of other system of medicine for a period of 14 weeks (equivalent to this study period). 4.Parents of CP children have given consent for the participation of their kids in the clinical trial during the study.

Exclusion criteria

Exclusion criteria: 1. Any C. P. child suffering from any associated acute systemic disorders, infective disorders, congenital disorders, myopathies of genetic origin or severe anemia. 2. Child suffering from progressive movement disorders or psychomotor retardation due to progressive degenerative disorders, ICSOL (Intracranial space occupying lesion), metabolic, and endocrinal disorders. 3. Patient/parent, who has denied to participate in the clinical trial during the study.

Design outcomes

Primary

MeasureTime frame
Developmental Milestones Range of MotionTimepoint: At registration and subsequent 2 follow-ups 4 weeks apart

Secondary

MeasureTime frame
AnthropometryTimepoint: At registration and subsequent 2 follow-ups 4 weeks apart

Countries

India

Contacts

Public ContactRajendra Kumar

Institute of Medical Sciences, B.H.U

hodkb2006@yahoo.in09415286910

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026